News

CAMH has applied for international patent protection for the diagnostic test designed by its scientist, Dr. John Vincent and co-inventors, and being developed by Athena Diagnostics. CAMH said

On 11 January, ReNeuron announced that it finalised and submitted the supplemental pre-clinical data package requested by the UK Gene Therapy Advisory Committee (GTAC), in support of the

Allowed claims cover the method of protecting a mammal from radiation using flagellin or its derivatives, including Protectan CBLB502. The US, nine member countries of the Eurasian Patent

The company said that Livea mimics the body’s natural signaling process making the body feel full, leading to weight loss. As the proprietary blend of ingredients is all-natural,

Reportedly, Eden, which will be a part of global brands division of Watson, will maintain its established contract services model, while providing the company with biopharmaceutical development and

Y C Lee, chief executive officer of Pacgen, said: “Pacgen is very pleased to collaborate with New Summit Bio to develop PAC-113 for the Chinese market. China represents

CTS-1027 is an oral, small molecule compound that inhibits the activity of key members of a class of protease enzymes, the matrix metalloproteinases or MMPs. CTS-1027’s anti-inflammatory and

The company said that its specialty amines such as DMAPAPA, TMPDA, DEAPA and APDEA offer the advantage of a multipurpose behavior in two-component systems, as they play a

The new approval strengthens the suite of over 60 approved patents and patent applications owned and licensed by the company. It cover all aspects of the company’s technology